Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse
Katsuyuki Tanabe(University of Colorado Denver), Takahiko Nakagawa(Shiga University), Peter W. Mathieson(University of Edinburgh), Miguel A. Lanaspa(University of Colorado Anschutz Medical Campus), Moin A. Saleem(University of Bristol), George F. Schreiner, Christopher J. Rivard(University of Colorado Denver), Hirofumi Makino(Okayama University Hospital), Jelena Klawitter(University of Colorado Anschutz Medical Campus), Richard J. Johnson(University of Colorado Anschutz Medical Campus), Wataru Kitagawa(Ito Hospital), Makoto Miyazaki(Chiba Cancer Center)
Cited by 56
Related Papers
The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited
|Journal of the American Society of Nephrology|2004|2k
The classification of glomerulonephritis in systemic lupus erythematosus revisited
|Kidney International|2004|1.7k
Evolving importance of kidney disease: from subspecialty to global health burden
|The Lancet|2013|1.2k
Loss of stearoyl–CoA desaturase-1 function protects mice against adiposity
|Proceedings of the National Academy of Sciences|2002|1.1k
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
|Journal of Hepatology|2018|938